Spineart Concludes Recruitment for BAGUERA C Investigational Device Exemption Study

Spineart has completed recruitment for their investigational device exemption study for their BAGUERA C prosthesis.  

The device is being studied for its ability to sustain movement and height in a specific part of the spine. It is intended for use after surgery to remove one or two cervical discs due to symptomatic cervical disc disease. The goal is to address issues related to the cervical spine and improve the patient’s condition.   

The main goal of the study is to determine how well BAGUERAC works in treating two neighboring levels, from C3 to C7, when compared to a commonly used commercial implant for replacing cervical discs in two levels.  

Jerome Trividic, the head executive of Spineart, stated, “The enrollment completion of our two-level BAGUERA C IDE study marks a significant milestone in Spineart’s ambition to emerge as a global leader in spine arthroplasty.”  

Trividic went on to add, “This unprecedented achievement underscores our commitment to advancing the adoption of cutting-edge technologies in spinal surgery. We eagerly anticipate bringing these two studies to fruition.” 

© Copyright 2010-2021 Zenopa LTD. All Rights Reserved.